CSF-VENTRICULAR PORT

Description of Event or Problem

MEDTRONIC RECEIVED INFORMATION REGARDING A VENTRICULAR PORT. IT WAS REPORTED THAT ON (b)(6) 2026, AN OMMAYA IMPLANTATION PROCEDURE WAS PERFORMED. DURING THE PROCEDURE, WATER LEAKAGE WAS IDENTIFIED IN THE CEREBROSPINAL FLUID SHUNT CATHETER AND ACCESSORY; THEREFORE, A REPLACEMENT WAS REQUESTED. THERE WAS A PROCEDURE DELAY OF 3 MINUTES. THE PATIENT'S STATUS AT THE TIME OF THE REPORT WAS ALIVE-NO INJURY.

Additional Manufacturer Narrative

MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.